Paula Martinez Marcos

Paula Martinez Marcos is a Senior Scientist at Bicycle Therapeutics since December 2022, focusing on target biology and stable cell line generation, alongside quantifying target expression through flow cytometry. Prior experience includes a Lead Scientist role at Lonza from November 2019 to December 2022, where Paula designed and evaluated CHOK1SV host-derived cell lines and developed new antibody expression systems using CRISPR/Cas technology. Paula served as a Research and Development Scientist at Aglaris Group from May 2017 to November 2019, managing the Cell Culture Department and coordinating research activities. Earlier experiences include research traineeships at Universidad de Zaragoza and Medical University of Lodz, emphasizing molecular techniques and enzymatic studies. Paula holds a Master's degree in Industrial and Environmental Biotechnology from Universidad Complutense de Madrid and a Bachelor's degree in Biotechnology from Universidad de Zaragoza.